ホーム>>Signaling Pathways>> Tyrosine Kinase>> FGFR>>H3B-6527

H3B-6527

カタログ番号GC19187

H3B-6527(H3バイオメディシン)は、FGF19増幅細胞株およびマウスにおいて強力な抗腫瘍活性を持つ高度選択的FGFR4阻害剤です。

Products are for research use only. Not for human use. We do not sell to patients.

H3B-6527 化学構造

Cas No.: 1702259-66-2

サイズ 価格 在庫数 個数
1mg
$54.00
在庫あり
5mg
$141.00
在庫あり
10mg
$241.00
在庫あり
25mg
$482.00
在庫あり
50mg
$870.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

H3B-6527 (H3 Biomedicine) is a highly selective FGFR4 inhibitor with potent antitumour activity in FGF19 amplified cell lines and mice.

References:
[1]. Dimitra Repana et al. Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma. Diseases 2015, 3, 294-305;

レビュー

Review for H3B-6527

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for H3B-6527

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.